Log in

Relevant bibliographies by topics / Battling cancer / Journal articles

To see the other types of publications on this topic, follow the link: Battling cancer.

Journal articles on the topic 'Battling cancer'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Battling cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

DELL, DEENA DAMSKY. "Battling breast cancer." Nursing Made Incredibly Easy! 3, no. 5 (2005): 4–20. http://dx.doi.org/10.1097/00152258-200509000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

&NA;. "Battling breast cancer." Nursing Made Incredibly Easy! 3, no. 5 (2005): 21. http://dx.doi.org/10.1097/00152258-200509000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Bristow, Nancy K. "Battling Breast Cancer." Reviews in American History 30, no. 1 (2002): 114–23. http://dx.doi.org/10.1353/rah.2002.0005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

JARVIS, LISA M. "BATTLING BREAST CANCER." Chemical & Engineering News Archive 84, no. 32 (2006): 21–27. http://dx.doi.org/10.1021/cen-v084n032.p021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Kiberstis, P. A. "BIOMEDICINE: Battling Pancreatic Cancer." Science 291, no. 5506 (2001): 949b—949. http://dx.doi.org/10.1126/science.291.5506.949b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Evans, Nancy. "On “battling breast cancer”." Geriatric Nursing 13, no. 6 (1992): 294–95. http://dx.doi.org/10.1016/s0197-4572(05)80369-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Kutler, Benton. "BATTLING CANCER IN NEBRASKA." Journal of the American Dental Association 130, no. 11 (1999): 1552–53. http://dx.doi.org/10.14219/jada.archive.1999.0073.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Thompson, Monte. "BATTLING CANCER IN UTAH." Journal of the American Dental Association 130, no. 11 (1999): 1553. http://dx.doi.org/10.14219/jada.archive.1999.0074.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Zanella, Fabian, and Amancio Carnero. "Battling cancer on many fronts." EMBO reports 9, no. 9 (2008): 853–58. http://dx.doi.org/10.1038/embor.2008.140.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Senior, Kathryn. "Battling cancer and the recession." Lancet Oncology 10, no. 3 (2009): 212–13. http://dx.doi.org/10.1016/s1470-2045(09)70057-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Foltz, Gregory. "New Hope for Battling Brain Cancer." Scientific American Mind 21, no. 1 (2010): 50–57. http://dx.doi.org/10.1038/scientificamericanmind0310-50.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Nikos, Giatrakos, Katzouris Nikos, Deligiannakis Antonios, et al. "Interactive Extreme-Scale Analytics Towards Battling Cancer." IEEE Technology and Society Magazine 38, no. 2 (2019): 54–61. https://doi.org/10.1109/MTS.2019.2913071.

Full text

Abstract:

A synergetic understanding of cancer evolution and the effect of combination drug therapies on the disease is the cornerstone for developing effective personalized treatments, which can radically improve patients' well-being and their quality of (work and social) life. By extension, improving the treatment of patients indirectly enhances the quality of life for families, friends, and careers. Moreover, personalizing effective therapeutic approaches reduces treatment duration, cutting down healthcare monetary costs, which can be redirected to other health and social services. Given that thr

APA, Harvard, Vancouver, ISO, and other styles

13

Chlichlia, K., V. Schirrmacher, and R. Sandaltzopoulos. "Cancer Immunotherapy: Battling Tumors with Gene Vaccines." Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents 4, no. 4 (2005): 353–65. http://dx.doi.org/10.2174/1568014054546290.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Langlands, Alan. "Battling breast cancer with dollars and sense." Medical Journal of Australia 161, no. 2 (1994): 105. http://dx.doi.org/10.5694/j.1326-5377.1994.tb127339.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Bansal, R. "Battling cancer: the latest on microwave hyperthermia." IEEE Microwave Magazine 6, no. 3 (2005): 32–34. http://dx.doi.org/10.1109/mmw.2005.1511909.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Giatrakos, Nikos, Miguel Ponce De Leon, Gian Gaetano Tartaglia, et al. "Interactive Extreme-Scale Analytics: Towards Battling Cancer." IEEE Technology and Society Magazine 38, no. 2 (2019): 54–61. http://dx.doi.org/10.1109/mts.2019.2913071.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Bell, John C. "Check and Checkmate: Battling Cancer with Multiplex Immunotherapy." Molecular Therapy 28, no. 5 (2020): 1236–37. http://dx.doi.org/10.1016/j.ymthe.2020.04.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Zheng, Lei. "Battling pancreatic cancer: the role of Chinese surgeons." Annals of Pancreatic Cancer 5 (October 2022): 10. http://dx.doi.org/10.21037/apc-2022-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Alarcon, Neftali Ortega, Maddy Jaramillo, Heidi M. Mansour, and Bo Sun. "Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms." Pharmaceutics 14, no. 7 (2022): 1448. http://dx.doi.org/10.3390/pharmaceutics14071448.

Full text

Abstract:

For decades, vaccines have played a significant role in protecting public and personal health against infectious diseases and proved their great potential in battling cancers as well. This review focused on the current progress of therapeutic subunit vaccines for cancer immunotherapy. Antigens and adjuvants are key components of vaccine formulations. We summarized several classes of tumor antigens and bioinformatic approaches of identification of tumor neoantigens. Pattern recognition receptor (PRR)-targeting adjuvants and their targeted delivery platforms have been extensively discussed. In a

APA, Harvard, Vancouver, ISO, and other styles

20

Lagasse, Eric. "Battling Cancer: In the End What Matters the Most?" Disruptive Science and Technology 1, no. 2 (2012): 108–9. http://dx.doi.org/10.1089/dst.2012.0018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Garofalo, Megan Resener. "Battling Environmental Racism in Cancer Alley: A Legislative Approach." Journal of Law, Medicine & Ethics 52, no. 1 (2024): 196–204. http://dx.doi.org/10.1017/jme.2024.64.

Full text

Abstract:

AbstractThis Paper argues that to protect at-risk communities — and all Americans — from the deadly effects of environmental racism, Congress must pass the Environmental Justice for All Act. The Act is intended to “restore, reaffirm, and reconcile environmental justice and civil rights.” It does so by restoring an individual’s right to sue in federal court for discrimination based on race, ethnicity, or national origin regardless of intent under the Civil Rights Act of 1964, strengthening the National Environmental Policy Act, and providing economic incentives focused on environmental justice.

APA, Harvard, Vancouver, ISO, and other styles

22

Lenihan, Victoria F., and Miguel A. Ramirez Sanchez. "Battling Psychiatric Disease: Lessons From the War on Cancer." American Journal of Psychiatry Residents' Journal 20, no. 3 (2025): 30–32. https://doi.org/10.1176/appi.ajp-rj.2025.200309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Imran, Mohammad, Areeba Insaf, Nazeer Hasan, et al. "Exploring the Remarkable Chemotherapeutic Potential of Polyphenolic Antioxidants in Battling Various Forms of Cancer." Molecules 28, no. 8 (2023): 3475. http://dx.doi.org/10.3390/molecules28083475.

Full text

Abstract:

Plant-derived compounds, specifically antioxidants, have played an important role in scavenging the free radicals present under diseased conditions. The persistent generation of free radicals in the body leads to inflammation and can result in even more severe diseases such as cancer. Notably, the antioxidant potential of various plant-derived compounds prevents and deregulates the formation of radicals by initiating their decomposition. There is a vast literature demonstrating antioxidant compounds’ anti-inflammatory, anti-diabetic, and anti-cancer potential. This review describes the molecul

APA, Harvard, Vancouver, ISO, and other styles

24

Lichtman, Marshall A. "Battling the Hematological Malignancies: The 200 Years' War." Oncologist 13, no. 2 (2008): 126–38. http://dx.doi.org/10.1634/theoncologist.2007-0228.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Ramos, Alisha, Samira Sadeghi, and Hossein Tabatabaeian. "Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them." International Journal of Molecular Sciences 22, no. 17 (2021): 9451. http://dx.doi.org/10.3390/ijms22179451.

Full text

Abstract:

With nearly 10 million deaths, cancer is the leading cause of mortality worldwide. Along with major key parameters that control cancer treatment management, such as diagnosis, resistance to the classical and new chemotherapeutic reagents continues to be a significant problem. Intrinsic or acquired chemoresistance leads to cancer recurrence in many cases that eventually causes failure in the successful treatment and death of cancer patients. Various determinants, including tumor heterogeneity and tumor microenvironment, could cause chemoresistance through a diverse range of mechanisms. In this

APA, Harvard, Vancouver, ISO, and other styles

26

Gude, Dilip. "Battling chemotherapy-induced nausea and vomiting in cancer palliative care." Indian Journal of Palliative Care 17, no. 1 (2011): 78. http://dx.doi.org/10.4103/0973-1075.78457.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Wilkinson, Scott, and Adam G. Sowalsky. "Battling the two-headed dragon of prostate cancer targeted therapy." Molecular & Cellular Oncology 7, no. 4 (2020): 1745037. http://dx.doi.org/10.1080/23723556.2020.1745037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Drugay, Marge. "Battling breast cancer in older women: Where do we stand?" Geriatric Nursing 13, no. 5 (1992): 240–44. http://dx.doi.org/10.1016/s0197-4572(05)80411-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Qureshi, Z., M. J. Lee, R. Horner, and C. Bennett. "Battling fear: a potential key to improving Colorectal Cancer Screening." Value in Health 18, no. 3 (2015): A50. http://dx.doi.org/10.1016/j.jval.2015.03.296.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Roark, Louanne. "Look Good … Feel Better Helps People Battling Cancer Help Themselves." Journal of Oncology Practice 4, no. 5 (2008): 262. http://dx.doi.org/10.1200/jop.0854502.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Thomson, Peter. "Battling oral cancer: revisiting prevention and intervention in clinical practice." Faculty Dental Journal 16, no. 3 (2025): 102–7. https://doi.org/10.1308/rcsfdj.2025.27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Dohan, Daniel, Robertina Szolarova, and Blue Walcer. "How a cancer education group serves the underserved: ‘Family’ ties and battling cancer." Patient Education and Counseling 87, no. 2 (2012): 212–16. http://dx.doi.org/10.1016/j.pec.2011.08.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Gianazza, Ugo. "In memoriam Emmanuele DiBenedetto (1947–2021)." Advances in Calculus of Variations 15, no. 1 (2021): 1–18. http://dx.doi.org/10.1515/acv-2021-2001.

Full text

Abstract:

Abstract Emmanuele DiBenedetto passed away in May 2021, after battling cancer for fifteen months. I have had the unique privilege to collaborate and discuss Mathematics with him, almost up to his final days. Here I briefly present his life and those mathematical results of his, which I consider most familiar with.

APA, Harvard, Vancouver, ISO, and other styles

34

Rafii, Saeed, Emad Tashkandi, Nedal Bukhari, and Humaid O. Al-Shamsi. "Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges." Cancers 14, no. 4 (2022): 947. http://dx.doi.org/10.3390/cancers14040947.

Full text

Abstract:

Cancer is considered by not only multiple genetic but also epigenetic amendments that drive malignant cell propagation and consult chemo-resistance. The ability to correct or ablate such mutations holds enormous promise for battling cancer. Recently, because of its great efficiency and feasibility, the CRISPR-Cas9 advanced genome editing technique has been extensively considered for therapeutic investigations of cancers. Several studies have used the CRISPR-Cas9 technique for editing cancer cell genomic DNA in cells and animal cancer models and have shown therapeutic potential in intensifying

APA, Harvard, Vancouver, ISO, and other styles

35

Sawanny, Rajni, Sheersha Pramanik, and Unnati Agarwal. "Role of Phytochemicals in the Treatment of Breast Cancer: Natural Swords Battling Cancer Cells." Current Cancer Therapy Reviews 17, no. 3 (2021): 179–96. http://dx.doi.org/10.2174/1573394716666210106123255.

Full text

Abstract:

Breast cancer is the most common type of malignancy among ladies (around 30% of newly diagnosed patients every year). To date, various modern treatment modalities for breast cancer, such as radiotherapy, surgical method, hormonal therapy, and chemotherapeutic drug utilisation, are available. However, adverse drug reactions, therapeutic resistance, metastasis, or cancer reoccurrence chances remain the primary causes of mortality for breast cancer patients. To overcome all the potential drawbacks, we need to investigate novel techniques and strategies that are not considered previously to treat

APA, Harvard, Vancouver, ISO, and other styles

36

Ling, Qing-Er, Si-Qi Ni, Yi Jiao, and Ling-Xiang Liu. "Unlocking the sun’s potential: Vitamin D’s role in battling colorectal cancer." Journal of Nutritional Oncology 9, no. 1 (2024): 1–9. https://doi.org/10.1097/jn9.0000000000000031.

Full text

Abstract:

Abstract Vitamin D, a fat-soluble hormone precursor primarily derived from sunlight exposure, exerts pleiotropic effects within the body, including anticancer activity. Research has demonstrated an association between vitamin D and colorectal cancer (CRC) from both geoecological and epidemiological perspectives, wherein vitamin D intake and circulating levels have clinical significance for the development of CRC and confer a protective effect against the disease. As such, a sensible increase in sunlight exposure may be an accessible approach to reducing cancer risk and a low-cost treatment whe

APA, Harvard, Vancouver, ISO, and other styles

37

Hoffman, Richard M., Richard G. Roberts, and Michael J. Barry. "Battling Prostate Cancer with 5-Alpha-Reductase Inhibitors: a Pyrrhic Victory?" Journal of General Internal Medicine 26, no. 7 (2011): 798–801. http://dx.doi.org/10.1007/s11606-010-1622-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Hu, Jieping, Gongxian Wang, and Ting Sun. "Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives." Tumor Biology 39, no. 5 (2017): 101042831769225. http://dx.doi.org/10.1177/1010428317692259.

Full text

Abstract:

Androgen receptor plays a pivotal role in prostate cancer progression, and androgen deprivation therapy to intercept androgen receptor signal pathway is an indispensable treatment for most advanced prostate cancer patients to delay cancer progression. However, the emerging of castration-resistant prostate cancer reminds us the alteration of androgen receptor, which includes androgen receptor mutation, the formation of androgen receptor variants, and androgen receptor distribution in cancer cells. In this review, we introduce the process of androgen receptor and also its variants’ formation, tr

APA, Harvard, Vancouver, ISO, and other styles

39

Isaak, Armond J., GeGe R. Clements, Rand Gabriel M. Buenaventura, Glenn Merlino, and Yanlin Yu. "Development of Personalized Strategies for Precisely Battling Malignant Melanoma." International Journal of Molecular Sciences 25, no. 9 (2024): 5023. http://dx.doi.org/10.3390/ijms25095023.

Full text

Abstract:

Melanoma is the most severe and fatal form of skin cancer, resulting from multiple gene mutations with high intra-tumor and inter-tumor molecular heterogeneity. Treatment options for patients whose disease has progressed beyond the ability for surgical resection rely on currently accepted standard therapies, notably immune checkpoint inhibitors and targeted therapies. Acquired resistance to these therapies and treatment-associated toxicity necessitate exploring novel strategies, especially those that can be personalized for specific patients and/or populations. Here, we review the current land

APA, Harvard, Vancouver, ISO, and other styles

40

Fateeva, Anna, Kevinn Eddy, and Suzie Chen. "Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance." Cancers 16, no. 8 (2024): 1571. http://dx.doi.org/10.3390/cancers16081571.

Full text

Abstract:

Melanoma is the most aggressive and deadly form of skin cancer due to its high propensity to metastasize to distant organs. Significant progress has been made in the last few decades in melanoma therapeutics, most notably in targeted therapy and immunotherapy. These approaches have greatly improved treatment response outcomes; however, they remain limited in their abilities to hinder disease progression due, in part, to the onset of acquired resistance. In parallel, intrinsic resistance to therapy remains an issue to be resolved. In this review, we summarize currently available therapeutic opt

APA, Harvard, Vancouver, ISO, and other styles

41

Walsh, Patrick C. "Re: Battling Prostate Cancer With 5-Alpha-Reductase Inhibitors: A Pyrrhic Victory?" Journal of Urology 186, no. 2 (2011): 530–31. http://dx.doi.org/10.1016/s0022-5347(11)60382-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

De Maeseneer, Daan Joost, Charles Van Praet, Nicolaas Lumen, and Sylvie Rottey. "Battling resistance mechanisms in antihormonal prostate cancer treatment: Novel agents and combinations." Urologic Oncology: Seminars and Original Investigations 33, no. 7 (2015): 310–21. http://dx.doi.org/10.1016/j.urolonc.2015.01.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Morales-Borges, Raúl H. "Christianity, Neurotheology & Cancer- Oncologic Christian Neuro Theology: New Era, Needs more attention." Alternative, Complementary & Integrative Medicine 7, no. 2 (2021): 1–4. http://dx.doi.org/10.24966/acim-7562/100172.

Full text

Abstract:

Many Christians are battling Cancer and there is a chaotic vortex of emotions that need resolving. They think they are alone. Religion and spirituality are fundamental to the human condition and play a role in our mental health and wellbeing. Initially, religion and science thrived in a complimentary relationship, only to be polarized with the aggressive secularization of science. We know that with the introduction of Neurotheology as a unique filed of scholarship and investigations that seek to understand the relationship specifically between the brain and theology, the cancer patients will f

APA, Harvard, Vancouver, ISO, and other styles

44

Brooks, Joanna Veazey, Claire Poague, and Taynara Formagini. "Battling Cancer or Fighting for Quality of Life? Role Theory and Patient Expectations in Cancer Care." Academy of Management Proceedings 2020, no. 1 (2020): 20996. http://dx.doi.org/10.5465/ambpp.2020.20996abstract.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Okwu, Gloria C., Theodora O. Nwosu-Zita, and Amina E. Haruna. "Abstract P4-05-07: Making Choices with Scarce Resources While Battling Breast Cancer In Nigeria." Cancer Research 83, no. 5_Supplement (2023): P4–05–07—P4–05–07. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-05-07.

Full text

Abstract:

Abstract Background Breast cancer diagnosis in Nigeria is perceived by most as a death sentence and women who have been diagnosed have to battle with different choices at any given time, whether to fight so as to survive, what if they fight and lose, or maybe it is better not to fight at all judging from different cases discussed during our monthly cancer patient support group meetings. Making informed choices with limited resources is the bane of many breast cancer patients who feel guilty spending so much on their medical care while their family suffers financial neglect. This is because hea

APA, Harvard, Vancouver, ISO, and other styles

46

Sadruddin, MunirMoosa, and M. Hameed-ur-Rehman. "Understanding the perceptions of children battling cancer about self and others through drawing." South Asian Journal of Cancer 2, no. 3 (2013): 113. http://dx.doi.org/10.4103/2278-330x.114100.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Dai, Enyan, Yiwei Sun, and Suhang Wang. "Ginger Cannot Cure Cancer: Battling Fake Health News with a Comprehensive Data Repository." Proceedings of the International AAAI Conference on Web and Social Media 14 (May 26, 2020): 853–62. http://dx.doi.org/10.1609/icwsm.v14i1.7350.

Full text

Abstract:

Nowadays, Internet is a primary source of attaining health information. Massive fake health news which is spreading over the Internet, has become a severe threat to public health. Numerous studies and research works have been done in fake news detection domain, however, few of them are designed to cope with the challenges in health news. For instance, the development of explainable is required for fake health news detection. To mitigate these problems, we construct a comprehensive repository, FakeHealth, which includes news contents with rich features, news reviews with detailed explanations,

APA, Harvard, Vancouver, ISO, and other styles

48

Vengadaragava Chary, Krishnan, and Anish Bharatwaj. "ONCOLYTIC VIRAL THERAPY IN CANCER THERAPEUTICS." Asian Journal of Pharmaceutical and Clinical Research 10, no. 10 (2017): 96. http://dx.doi.org/10.22159/ajpcr.2017.v10i10.19265.

Full text

Abstract:

Objective: The aim of this study is to provide comprehensive information of oncolytic viral therapy, from the origin to present scenario.Methods: This observational study was conducted by the Department of Pharmacology, Saveetha Medical College, Chennai between July and December 2016. Date regarding ongoing oncolytic virotherapy trials was retrieved from clinical trial database, United States and Clinical trial registry forum, India. Tamilnogene approval details were obtained from the US-Food and Drug Administration approval new drug approval information.Results: Eleven ongoing trials in Phase

APA, Harvard, Vancouver, ISO, and other styles

49

Scarcia, Marcello, Giuseppe Mario Ludovico, Angela Fortunato, and Alba Fiorentino. "Patients with cancer in the COVID-19 era: the clinical trial issue." Tumori Journal 106, no. 4 (2020): 271–72. http://dx.doi.org/10.1177/0300891620933672.

Full text

Abstract:

Coronavirus disease 2019 (COVID-19) hospital reorganization may result in reduced ability for the hospital to fully use its armamentarium for battling cancer. Thus different therapeutic modalities have been recommended. During the pandemic, despite regulatory agencies’ recommendations, several considerations and doubts remain for oncologic clinical trials. Considering patients who had been enrolled before the pandemic, and who plan to take the study medication, the situation becomes complicated. These patients should undergo monitoring visits, blood sampling, questionnaire, physical examinatio

APA, Harvard, Vancouver, ISO, and other styles

50

Jain, Meenu, Dhananjay Yadav, Urmila Jarouliya, et al. "Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis." Pathogens 12, no. 12 (2023): 1380. http://dx.doi.org/10.3390/pathogens12121380.

Full text

Abstract:

Human papillomavirus (HPV) is implicated in over 90% of cervical cancer cases, with factors like regional variability, HPV genotype, the population studied, HPV vaccination status, and anatomical sample collection location influencing the prevalence and pathology of HPV-induced cancer. HPV-16 and -18 are mainly responsible for the progression of several cancers, including cervix, anus, vagina, penis, vulva, and oropharynx. The oncogenic ability of HPV is not only sufficient for the progression of malignancy, but also for other tumor-generating steps required for the production of invasive canc

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!